
Now is the ideal time to review existing policies and protocols pertaining to DEA & pharmaceutical regulatory compliance for 2026
As 2025 winds down, pharmaceutical and controlled substance manufacturers are facing a shifting compliance landscape. Now is the ideal time to prepare for DEA regulatory





